C11orf21: A Potential Drug Target Or Biomarker (G29125)

Target Name: C11orf21

NCBI ID: G29125

C11orf21

C11orf21: A Potential Drug Target Or Biomarker

C11orf21, also known as chromosome 11 open reading frame 21, is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its unique genetic mutation has been found to be associated with a range of clinical features, including increased risk of certain cancers, obesity, and neurodegeneration.

The C11orf21 gene is located on chromosome 11, which is one of the most highly conserved regions of the human genome. It encodes a protein that is involved in a variety of cellular processes, including cell signaling, DNA replication, and stress response. The open reading frame (ORF) 21 region of the gene is a stretch of DNA that is known to be involved in the regulation of protein translation, which is the process by which cells translate the information in mRNA into proteins.

Studies have identified a number of potential drug targets or biomarkers for C11orf21. One of the most promising targets is the protein p18, which is a known interactor with the C11orf21 gene. p18 is a transcription factor that has been shown to promote the translation of C11orf21 mRNA into protein, and may be a useful target for drugs that are designed to inhibit p18 function.

Another potential target for C11orf21 is the neurodegenerate protein alpha-synuclein, which is a protein that is abnormally increased in some neurodegenerative diseases. Research has found that variations in the C11orf21 gene are related to abnormal expression of 伪-synuclein, which provides a new idea for finding and treating these diseases.

In addition, variations in the C11orf21 gene are also associated with metabolic diseases such as obesity and diabetes. Research has found that variations in the C11orf21 gene are associated with an increased risk of obesity and diabetes, which provides a new target for the development and treatment of diseases such as obesity and diabetes.

In addition, variations in the C11orf21 gene are also related to mental health. Research has found that variations in the C11orf21 gene are associated with an increased risk of mental health diseases such as depression, which provides a new idea for the development and treatment of these diseases.

In summary, C11orf21 is a very promising drug target or biomarker with broad application prospects. Future research will continue to deeply explore the relationship between C11orf21 gene variations and diseases, and develop new drugs or biomarkers to treat and prevent these diseases.

Protein Name: Chromosome 11 Open Reading Frame 21

The "C11orf21 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C11orf21 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets